"Cognitive Dysfunction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diminished or impaired mental and/or intellectual function.
- Cognitive Dysfunction
- Cognitive Dysfunctions
- Dysfunction, Cognitive
- Dysfunctions, Cognitive
- Cognitive Impairments
- Cognitive Impairment
- Impairment, Cognitive
- Impairments, Cognitive
Mild Cognitive Impairment
- Mild Cognitive Impairment
- Cognitive Impairment, Mild
- Cognitive Impairments, Mild
- Impairment, Mild Cognitive
- Impairments, Mild Cognitive
- Mild Cognitive Impairments
- Mild Neurocognitive Disorder
- Disorder, Mild Neurocognitive
- Disorders, Mild Neurocognitive
- Mild Neurocognitive Disorders
- Neurocognitive Disorder, Mild
- Neurocognitive Disorders, Mild
- Cognitive Decline
- Cognitive Declines
- Decline, Cognitive
- Declines, Cognitive
- Mental Deterioration
- Deterioration, Mental
- Deteriorations, Mental
- Mental Deteriorations
Below are MeSH descriptors whose meaning is more general than "Cognitive Dysfunction".
Below are MeSH descriptors whose meaning is more specific than "Cognitive Dysfunction".
This graph shows the total number of publications written about "Cognitive Dysfunction" by people in this website by year, and whether "Cognitive Dysfunction" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Cognitive Dysfunction" by people in Profiles.
Lu K, Xiong X, Horras A, Jiang B, Li M. Impact of financial barriers on health status, healthcare utilisation and economic burden among individuals with cognitive impairment: a national cross-sectional survey. BMJ Open. 2022 05 04; 12(5):e056466.
Wolf V, Abdul Y, Li W, Ergul A. Impact of diabetes and ischemic stroke on the cerebrovasculature: A female perspective. Neurobiol Dis. 2022 06 01; 167:105667.
Li P, Wu Y, Hamlett ED, Goodwin AJ, Halushka PV, Carroll SL, Liu M, Fan H. Suppression of Fli-1 protects against pericyte loss and cognitive deficits in Alzheimer's disease. Mol Ther. 2022 04 06; 30(4):1451-1464.
O'Toole SM, Walker RJ, Garacci E, Dawson AZ, Campbell JA, Egede LE. Explanatory role of sociodemographic, clinical, behavioral, and social factors on cognitive decline in older adults with diabetes. BMC Geriatr. 2022 01 10; 22(1):39.
Jutten RJ, Thompson L, Sikkes SAM, Maruff P, Molinuevo JL, Zetterberg H, Alber J, Faust D, Gauthier S, Gold M, Harrison J, Lee AKW, Snyder PJ. A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach. J Alzheimers Dis. 2022; 86(2):511-524.
Sen S, An H, Sollman M, Oakes J, Eron J, Robertson K, Powers W. Reduction in cerebral oxygen metabolism in subcortical regions may be a biomarker of cognitive decline in people living with human immunodeficiency virus. Eur J Neurol. 2022 04; 29(4):1062-1074.
Martinez M, Dawson AZ, Lu K, Walker RJ, Egede LE. Effect of cognitive impairment on risk of death in Hispanic/Latino adults over the age of 50 residing in the United States with and without diabetes: Data from the Health and Retirement Study 1995-2014. Alzheimers Dement. 2022 Sep; 18(9):1616-1624.
Erichsen JM, Fadel JR, Reagan LP. Peripheral versus central insulin and leptin resistance: Role in metabolic disorders, cognition, and neuropsychiatric diseases. Neuropharmacology. 2022 02 01; 203:108877.
Jang Y, Haley WE, Choi EY, Franco Y. Racial/Ethnic Differences in Correspondence Between Subjective Cognitive Ratings and Cognitive Impairment. Am J Geriatr Psychiatry. 2022 05; 30(5):627-635.
Lazar RM, Wadley VG, Myers T, Jones MR, Heck DV, Clark WM, Marshall RS, Howard VJ, Voeks JH, Manly JJ, Moy CS, Chaturvedi S, Meschia JF, Lal BK, Brott TG, Howard G. Baseline Cognitive Impairment in Patients With Asymptomatic Carotid Stenosis in the CREST-2 Trial. Stroke. 2021 12; 52(12):3855-3863.